When shouldCandida isolates be tested for susceptibility to azole antifungal agents?
- 1 April 1997
- journal article
- editorial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 16 (4), 281-282
- https://doi.org/10.1007/bf01695631
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Azole resistance inCandidaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Fluconazole disk diffusion procedure for determining susceptibility of Candida speciesJournal of Clinical Microbiology, 1996
- Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factorsAntimicrobial Agents and Chemotherapy, 1996
- Fluconazole treatment of Candidal infections caused by non-Albicans Candida speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersAntimicrobial Agents and Chemotherapy, 1995
- Resistance of Candida species to fluconazoleAntimicrobial Agents and Chemotherapy, 1995
- Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupAntimicrobial Agents and Chemotherapy, 1995